Sabrina Paganoni

Sabrina Paganoni, MD, PhD, is an assistant professor at Harvard Medical School and works as a physician scientist at the Healey Center for ALS at Massachusetts General Hospital. Dr. Paganoni’s research focuses on therapy development for ALS. She designed and is currently leading several ALS clinical trials that include novel endpoints and biomarkers and innovative trial designs. She is the co-principal investigator for the HEALEY ALS Platform Trial.

Dr. Paganoni received her medical degree from the University of Milan, Italy, and her PhD in neuroscience from Northwestern University. She completed her residency and fellowship training in Boston in the Harvard Medical School hospital system. Dr. Paganoni has published more than70 peer-reviewed papers. Her research has been funded by the NIH, foundations, and industry. She received several awards for her work including the NIH Rehabilitation Medicine Scientist Training Program Award (2012), the American Academy of Neurology / ALS Association Three-Year Career Development Award in ALS (2017), and the American Association of Neuromuscular & Electrodiagnostic Medicine Scientific Impact Award (2019).